Literature DB >> 16253652

Rate control vs rhythm control strategies in atrial fibrillation.

D George Wyse1.   

Abstract

Rhythm management for atrial fibrillation is a subject of intense interest. In this review, the two main strategies for rhythm management in atrial fibrillation, the "heart rate control" strategy and the "heart rhythm control" strategy, are discussed under several headings. Some of the basic issues surrounding heart rate control and heart rhythm control and their study in clinical trials are reviewed. Seven published trials that deal with a comparison of these two strategies are reviewed in some detail. In summary, no distinct advantage of the rhythm control strategy has been identified so far. With respect to pharmacologic therapies and the type of patient studied in most of these trials, advantages seem to accrue to the rate control strategy. Those advantages include fewer adverse drug effects, fewer hospitalizations, and lower cost. Two trials studying quite different patients, and in one case quite different drug therapies, are currently in progress, and these two trials are also briefly reviewed. Current guidelines have not taken into account fully the findings of the studies described in this review, and comment is offered on the current guidelines. Finally, some of the possibilities for future research around this question are highlighted.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16253652     DOI: 10.1016/j.pcad.2005.06.008

Source DB:  PubMed          Journal:  Prog Cardiovasc Dis        ISSN: 0033-0620            Impact factor:   8.194


  6 in total

1.  Atrial fibrillation: challenges and opportunities.

Authors:  Ahmad Hersi; L Brent Mitchell; D George Wyse
Journal:  Can J Cardiol       Date:  2006-08       Impact factor: 5.223

Review 2.  Medical management of atrial fibrillation.

Authors:  Ahmad Hersi; D George Wyse
Journal:  Curr Cardiol Rep       Date:  2006-09       Impact factor: 2.931

Review 3.  Pharmacotherapy for rhythm management in elderly patients with atrial fibrillation.

Authors:  D George Wyse
Journal:  J Interv Card Electrophysiol       Date:  2009-01-16       Impact factor: 1.900

Review 4.  Twenty-five years in the making: flecainide is safe and effective for the management of atrial fibrillation.

Authors:  Etienne Aliot; Alessandro Capucci; Harry J Crijns; Andreas Goette; Juan Tamargo
Journal:  Europace       Date:  2010-12-07       Impact factor: 5.214

5.  Chronic kidney disease and arrhythmias: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Authors:  Mintu P Turakhia; Peter J Blankestijn; Juan-Jesus Carrero; Catherine M Clase; Rajat Deo; Charles A Herzog; Scott E Kasner; Rod S Passman; Roberto Pecoits-Filho; Holger Reinecke; Gautam R Shroff; Wojciech Zareba; Michael Cheung; David C Wheeler; Wolfgang C Winkelmayer; Christoph Wanner
Journal:  Eur Heart J       Date:  2018-06-21       Impact factor: 29.983

6.  Comparison of Atrial Fibrillation in the Young versus That in the Elderly: A Review.

Authors:  Rajiv Sankaranarayanan; Graeme Kirkwood; Katharine Dibb; Clifford J Garratt
Journal:  Cardiol Res Pract       Date:  2013-01-22       Impact factor: 1.866

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.